SCHEMBL29453726

SCHEMBL29453726

N#CC1(Cc2ccc(C(F)(F)F)cc2)CCN(C(=O)c2cccnc2-c2ccncc2)CC1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP46A1 Q9Y6A2 11/20 0.60
▸ CYP3A4 P08684 5/20 0.60
▸ CYP2C9 P11712 3/20 0.60
▸ CYP2C19 P33261 2/20 0.60
▸ CYP2C8 P10632 1/20 0.60
▸ SLC6A7 Q99884 1/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ USP2 O75604 4/20 0.39
▸ TSHR P16473 2/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP1A2 P05177 1/20 0.38
▸ ACACA Q13085 1/20 0.38
▸ EPHX2 P34913 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22719206 1.00 CYP46A1 (0.60) CYP46A1CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL22719284 0.92 CYP46A1 (0.68) CYP46A1CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL29453769 0.92 CYP46A1 (0.68) CYP46A1CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL29453812 0.91 CYP46A1 (0.57) CYP46A1CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL22719411 0.91 CYP46A1 (0.57) CYP46A1CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL22719455 0.91 CYP46A1 (0.62) CYP46A1CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL29453641 0.91 CYP46A1 (0.62) CYP46A1CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL29453767 0.90 CYP46A1 (0.74) CYP46A1CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL22719476 0.90 CYP46A1 (0.74) CYP46A1CYP3A4CYP2C9CYP2C19CYP2C8
SCHEMBL22719352 0.90 CYP46A1 (0.61) CYP46A1CYP3A4CYP2C9CYP2C19CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3976186-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Sage Therapeutics, Inc. (US) 2022-04-06 — — EP disclosed
Send feedback